1. Baker DL, Zack M, Miles JW, Alderman L, Warren M, Dobbin RD, Miller S, and Teeters WR (1978). Epidemic malathion poisoning in Pakistan malaria workers. Lanceti: 31–34.
2.
2. Dinsdale D, Verschoyle RD, and Ingham JE (1984). Ultrastructural changes in rat clara cells induced by a single dose of O,S,S-trimethyl phosphorodithioate. Arch. Toxicol.56: 59–65.
3.
3. Durham SK, Boyd MR, and Castleman WL (1985). Pulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice. Am. J. Pathol.118: 66–75.
4.
4. Durham SK, Mezza LE, and Imamura T (1988). Pulmonary endothelial and alveolar epithelial lesions induced by O,O,S-trimethyl phosphorothioate in rats. J. Pathol.155: 247–257.
5.
5. Karnovsky MJ (1965). A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy.J. Cell. Biol.27: 137A–138A.
6.
6. Mallipudi NM, Umetsu N, Toia RF, Talcott RE, and Fukuto TR (1979). Toxicity of O,O,S-trimethyl and triethyl phosphorothioate in the rat. J. Agric. Food Chem.27: 463–466.
7.
7. Pellegrini G and Santi R (1972). Potentiation of toxicity of organophosphorus compounds containing carboxylic ester functions towards warm-blooded animals by some organophosphorus impurities. J. Agric. Food Chem.20: 944–950.
8.
8. Schuchman SM (1980). Individual care and treatment of rabbits, mice, rats, guinea pigs, hamsters, and gerbils. In: Current Veterinary Therapy VII, RW Kirk (ed). WB Saunders Co., Philadelphia, pp. 741–767.
9.
9. Umetsu N, Grose FH, Allahyari R, Abu-El-Haj S, and Fukuto TR (1977). Effect of impurities on the mammalian toxicity of technical malathion and acephate. J. Agric. Food Chem.25: 946–953.
10.
10. van Hooft JIM (1987). Survey of mouse and rat breeding colonies at REP Institutes TNO (internal publication), pp. 15–16.
11.
11. Verschoyle RD and Cabral JRP (1982). Investigation of the acute toxicity of some trimethyl and triethyl phosphorothioates with particular reference to those causing lung damage. Arch. Toxicol.51: 221–231.
12.
12. Weil CS (1952). Tables for convenient calculation of median-effective dose (LD50 or ED 50) and instructions in their use. Biometrics8: 249–263.